NCT/Study#
NCT05570253 /
MSK22-074
Phase 2 Randomized Control Trial of Evexomostat (SDX-7320) in Combination with Eribulin for Patients with Metastatic Triple-Negative Breast Cancer and Metabolic Dysfunction: The ARETHA Study
DISEASE GROUP:
Breast Cancer Clinical Trials
current phase:
Unspecified
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
